Life Sciences Collaborative Agreements and Acquisitions

Wednesday, February 27 – Thursday, February 28 2013

Location: The Carlton Hotel, New York, NY

Maximizing Opportunities and Rewards in M&A, Licensing, Partnering Deals, and Strategic Alliances
Wednesday, February 27 to Thursday, February 28, 2013
The Carlton Hotel, New York, NY

At American Conference Institute’s 17th Advanced Forum on Life Sciences Collaborative Agreements and Acquisitions, a seasoned faculty of business development, licensing, and alliance management executives from top life sciences companies like Pfizer, AstaZeneca, GlaxoSmithKline, Sanofi Pasteur, Novartis, and Bayer will help you enable your company to advance its key growth strategies.

Leading licensing, business development, and M&A executives, seasoned in-house
counsel, and top IP professionals will share their hard-won insights and fi rst-hand
experiences on how to:

• INCORPORATE the right takeaways from recent deals into your business development strategies

• MINIMIZE risks with effective due diligence systems and effective partner selection

• STRUCTURE deals that are able meet both parties’ goals

• DRAFT termination provisions to effectively avoid problems with deals that do not work out

• UTILIZE contract research organizations and other entities to limit R&D expenditures

• EVALUATE and EXECUTE milestone based compensation structures

• RESOLVE issues in collaboration with universities

• NEGOTIATE acquisitions that satisfy your business objectives

For more information, please visit our website: www.americanconference.com/Collaborations

** MassBio members are entitled to a discount when referencing the code: MASSBIO 300 **

Share MassBio

 

Janitronics

EvaluatePharma


 

MassBio